PHAXIAM Therapeutics S.A. Share Premium
PHAXIAM Therapeutics S.A. had Share Premium of EUR 49.67 million as of 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Notes
ifrs-full:SharePremium · last filed 2023-09-26
- 2023-06-30: Share Premium 49.67M EUR.
- 2022-12-31: Share Premium 48.98M EUR.
- 2022-06-30: Share Premium 48.98M EUR.
- 2021-12-31: Share Premium 97.62M EUR.
| Period end | Share Premium | Share Premium as first filed |
|---|---|---|
| 2023-06-30 | 49.67M EUR 6-K · filed 2023-09-26 | |
| 2022-12-31 | 48.98M EUR 6-K · filed 2023-09-26 | |
| 2022-06-30 | 48.98M EUR 6-K · filed 2022-09-12 | |
| 2021-12-31 | 97.62M EUR 20-F · filed 2023-03-28 | |
| 2021-06-30 | 86.21M EUR 6-K · filed 2021-09-20 | |
| 2020-12-31 | 120.70M EUR 20-F · filed 2023-03-28 | |
| 2020-06-30 | 108.31M EUR 6-K · filed 2020-09-21 | |
| 2019-12-31 | 281.69M EUR 20-F · filed 2022-04-27 | |
| 2019-06-30 | 281.69M EUR 6-K · filed 2019-09-26 | |
| 2018-12-31 | 281.74M EUR 20-F · filed 2021-03-08 | 281.75M EUR 20-F · filed 2019-03-29 |
| 2017-12-31 | 281.75M EUR 20-F · filed 2020-03-18 | |
| 2016-12-31 | 105.09M EUR 20-F · filed 2019-03-29 | |
| 2015-12-31 | 95.93M EUR 20-F/A · filed 2018-05-23 |